poor-risk advanced rcc: tki therapy & outlook
Published 4 years ago • 78 plays • Length 3:33Download video MP4
Download video MP3
Similar videos
-
4:06
selecting therapy for poor-risk advanced rcc
-
4:23
second-line options for poor-risk advanced rcc
-
2:44
surgery for poor-risk advanced renal cell carcinoma
-
2:53
case based overview: poor-risk advanced renal cell carcinoma
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
1:15
immunotherapy/tki combinations in advanced rcc
-
6:02
risk stratification of patients with advanced rcc
-
5:25
advanced rcc treatment selection
-
1:37
immunotherapy combinations improve survival in advanced renal cell carcinoma
-
3:11
treatment options for intermediate/poor-risk rcc
-
5:32
lenvatinib and everolimus for advanced rcc
-
4:14
second-line treatment options for advanced rcc
-
2:55
initial management of advanced rcc
-
5:12
advanced rcc: prognosis and therapy selection
-
1:30
targeted therapies for the treatment of mrcc after nivolumab-ipilimumab failure
-
1:58
risk stratification in advanced renal cell cancer
-
1:03:29
rcc: current applications, controversies, and future use of immunotherapy and targeted agents
-
8:57
determining initial therapeutic approach in advanced rcc
-
34:02
auau podcast: targeted therapies in renal cell carcinoma